A PE-PGRS33 protein of Mycobacterium tuberculosis: An ideal target for future tuberculosis vaccine design

Paola Gastelum-Aviña, Carlos Velazquez, Clara Espitia, Fernando Lares-Villa, Adriana Garibay-Escobar*

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

12 Citas (Scopus)

Resumen

It is known that cellular immune response is relevant to fight against tuberculosis (TB); hence, identification of mycobacterial antigens that induce a protective immune cellular response is of great interest, especially for the development of effective TB vaccines. Genomic data have an impact on the identification of potential antigens as new vaccine targets. In this review, we summarize the current knowledge about the advances in new TB vaccine designs as well as the features reported for the pro-glu-polymorphic GC-rich sequence (PE-PGRS33) protein, considering this molecule as a prototype of the PE-PGRS family to better understand the biological function of this protein family that could be considered an ideal target for future vaccine design.

Idioma originalInglés
Páginas (desde-hasta)699-711
Número de páginas13
PublicaciónExpert Review of Vaccines
Volumen14
N.º5
DOI
EstadoPublicada - 1 may. 2015

Nota bibliográfica

Publisher Copyright:
© Informa UK, Ltd.

Huella

Profundice en los temas de investigación de 'A PE-PGRS33 protein of Mycobacterium tuberculosis: An ideal target for future tuberculosis vaccine design'. En conjunto forman una huella única.

Citar esto